徐脈治療デバイス市場- 世界の産業規模、シェア、動向、機会、予測、タイプ別、デバイス別、エンドユーザー別、地域別、競争別、2020-2030F

徐脈治療デバイスデバイスの世界市場規模は、2024年に92億1,000万米ドルとなり、2030年には123億8,000万米ドルに達すると予測され、予測期間中の年間平均成長率（CAGR）は5.03％で拡大します。

この成長の主な要因は、心血管疾患の罹患率の増加と高度なペースメーカー技術の採用が増加していることです。

異常に遅い心拍数を特徴とする徐脈は、高齢化社会の中でますます蔓延しており、効果的な治療ソリューションに対する需要の高まりに寄与しています。同市場は、リードレスペースメーカー、MRI対応機器、遠隔モニタリングシステムなどの技術進歩の恩恵を受けており、これらはすべて臨床転帰を改善し、合併症のリスクを低減するように設計されています。

電気生理学と心臓リズム管理における継続的な技術革新は、徐脈治療デバイスの採用をさらに加速させています。さらに、保険償還政策や低侵襲手術技術の進歩により、より多くの患者が治療を受けられるようになりました。

ヘルスケア投資の増加や医療機器メーカーと研究機関の戦略的提携も市場拡大に重要な役割を果たしています。技術の進歩は、早期診断と早期介入に対する意識の高まりと相まって、さらなる需要を促進しています。

人工知能（AI）が心臓モニタリングシステムに統合されたことで、徐脈の検出精度が大幅に向上し、タイムリーな治療が容易になりました。電池寿命の延長と安全性プロファイルの強化を特徴とするワイヤレス・ペースメーカーが広く受け入れられつつあり、繰り返し外科手術を行う必要性を最小限に抑えています。遠隔患者モニタリングはますます普及しており、心臓の健康状態をリアルタイムで追跡し、より迅速な治療調整を可能にしています。低侵襲手術への嗜好は、革新的なペースメーカー植え込み技術の開発を促進し、従来の手術に伴う一般的なリスクを軽減しています。

主な市場促進要因

心血管疾患の有病率の上昇

主な市場課題

認知度の低下と過小診断

主要市場動向

埋め込み型デバイスの小型化と進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の徐脈治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（洞性徐脈、洞停止、洞不全症候群、頻脈徐脈症候群、心ブロック）
  • 機器別（ペースメーカー（単腔ペースメーカー、二腔ペースメーカー）、除細動器）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • タイプ別
  • デバイス別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の徐脈治療デバイス市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別
  • デバイス別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の徐脈治療デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の徐脈治療デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
  • タイプ
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の徐脈治療デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの徐脈治療デバイス市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の徐脈治療デバイス市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Abbott Laboratories
• Biotronik
• Nihon Kohden Corporation
• Lepu Medical Technology（Beijing）Co Ltd.
• Medico S.R.L.
• Oscor Inc
• Osypka Medical Inc.
• Microport Scientific Corporation
• Boston Scientific Corporation
• Medtronic Plc.

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Bradycardia Treatment Devices Market devices was valued at USD 9.21 billion in 2024 and is projected to reach USD 12.38 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.03% during the forecast period. This growth is primarily driven by the increasing incidence of cardiovascular diseases and the rising adoption of advanced pacemaker technologies.

Bradycardia, characterized by an unusually slow heart rate, is increasingly prevalent among the aging population, contributing to a heightened demand for effective treatment solutions. The market is benefiting from technological advancements such as leadless pacemakers, MRI-compatible devices, and remote monitoring systems, all of which are designed to improve clinical outcomes and reduce the risk of complications.

Ongoing innovations in electrophysiology and cardiac rhythm management have further accelerated the adoption of bradycardia treatment devices. Additionally, supportive reimbursement policies and progress in minimally invasive surgical techniques have enhanced accessibility, prompting a greater number of patients to pursue treatment.

Increased healthcare investments and strategic collaborations between medical device manufacturers and research institutions are also playing a vital role in market expansion. Technological advancements, coupled with rising awareness about early diagnosis and intervention, are driving further demand.

The integration of artificial intelligence (AI) into cardiac monitoring systems has significantly enhanced the accuracy of bradycardia detection, facilitating timely treatment. Wireless pacemakers featuring extended battery life and enhanced safety profiles are gaining wider acceptance, minimizing the need for repeated surgical procedures. Remote patient monitoring is becoming increasingly prevalent, enabling real-time tracking of cardiac health and more responsive treatment adjustments. The preference for minimally invasive procedures has fostered the development of innovative pacemaker implantation techniques, reducing the risks typically associated with conventional surgeries.

Key Market Drivers

Rising Prevalence of Cardiovascular Diseases

The increasing global burden of cardiovascular diseases (CVDs) is a major factor propelling growth in the bradycardia treatment devices market. According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide, accounting for approximately 17.9 million fatalities annually. This includes conditions such as heart failure, coronary artery disease, and arrhythmias, with bradycardia being a common manifestation.

The aging global population and increasingly sedentary lifestyles are contributing to a higher incidence of CVDs, expanding the potential patient base for bradycardia treatments. Enhanced diagnostic capabilities and growing awareness of heart-related conditions have empowered healthcare providers to detect and monitor bradycardia more effectively, leading to earlier interventions and greater demand for treatment devices.

Government initiatives and public health strategies aimed at combating cardiovascular diseases are further supporting the adoption of bradycardia treatment technologies. For instance, in Europe, 82% of CVD-related deaths in 2019 were attributed to heart attacks and strokes, highlighting the urgency for preventive care and timely intervention-areas where bradycardia treatment devices play a critical role.

Key Market Challenges

Limited Awareness and Underdiagnosis

A significant barrier to market growth is the limited awareness and underdiagnosis of bradycardia. Despite its potential health implications, the condition often goes unnoticed or is misdiagnosed due to its subtle or intermittent symptoms.

Many individuals with mild bradycardia may not exhibit noticeable signs such as dizziness, fatigue, or fainting, leading them to forgo medical consultation. This contributes to a large number of undiagnosed cases and delays in treatment. Additionally, some healthcare professionals may overlook the more nuanced symptoms of bradycardia, particularly when they occur sporadically, further contributing to underdiagnosis.

Early detection is essential for effective management and the prevention of complications. However, the lack of awareness-both among the general public and within the medical community-remains a critical challenge to the timely identification and treatment of the condition.

Key Market Trends

Miniaturization and Advancement of Implantable Devices

The miniaturization of devices and innovations in implantable technologies are transforming the bradycardia treatment landscape. These trends are central to the advancement of cardiac rhythm management and have significantly enhanced patient outcomes.

Modern pacemakers and implantable cardioverter-defibrillators (ICDs) are now substantially smaller and less obtrusive, making them easier to implant and more comfortable for patients. This reduction in device size contributes to less invasive procedures, faster recovery times, and decreased surgical risk-particularly beneficial for elderly patients or those with higher surgical risks.

Miniaturized devices have also expanded the range of patients eligible for implantation, including those with smaller anatomical structures. Implantable devices now feature advanced functionalities such as adaptive pacing algorithms and remote monitoring capabilities. These features enable healthcare providers to monitor patients' cardiac rhythms in real-time, allowing for timely adjustments and more personalized treatment plans.

Key Market Players

• Abbott Laboratories
• Biotronik
• Nihon Kohden Corporation
• Lepu Medical Technology (Beijing)Co Ltd.
• Medico S.R.L.
• Oscor Inc
• Osypka Medical Inc.
• Microport Scientific Corporation
• Boston Scientific Corporation
• Medtronic Plc

Report Scope:

In this report, the Global Bradycardia Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bradycardia Treatment Devices Market, By Type:

• Sinus Bradycardia
• Sinus Pause
• Sick Sinus Syndrome
• Tachy-brady Syndrome
• Heart Block

Bradycardia Treatment Devices Market, By Devices:

• Pacemakers
• Defibrillator

Bradycardia Treatment Devices Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Bradycardia Treatment Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bradycardia Treatment Devices Market.

Available Customizations:

Global Bradycardia Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bradycardia Treatment Devices Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Sinus Bradycardia, Sinus Pause, Sick Sinus Syndrome, Tachy-brady Syndrome, Heart Block)
  • 4.2.2. By Devices (Pacemakers{Single Chamber Pacemaker, Dual Chamber Pacemaker}, Defibrillator)
  • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Devices
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Bradycardia Treatment Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Devices
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Bradycardia Treatment Devices Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Devices
      • 5.3.1.2.3. By End User
  • 5.3.2. India Bradycardia Treatment Devices Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Devices
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Bradycardia Treatment Devices Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Devices
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Bradycardia Treatment Devices Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Devices
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Bradycardia Treatment Devices Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Devices
      • 5.3.5.2.3. By End User

6. Europe Bradycardia Treatment Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Devices
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Bradycardia Treatment Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Devices
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Bradycardia Treatment Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Devices
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Bradycardia Treatment Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Devices
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Bradycardia Treatment Devices Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Devices
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Bradycardia Treatment Devices Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Devices
      • 6.3.5.2.3. By End User

7. North America Bradycardia Treatment Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Drug Type
  • 7.2.2. Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Bradycardia Treatment Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Devices
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Bradycardia Treatment Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Devices
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Bradycardia Treatment Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Devices
      • 7.3.3.2.3. By End User

8. South America Bradycardia Treatment Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Devices
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Bradycardia Treatment Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Devices
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Bradycardia Treatment Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Devices
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Bradycardia Treatment Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Devices
      • 8.3.3.2.3. By End User

9. Middle East and Africa Bradycardia Treatment Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Devices
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Bradycardia Treatment Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Devices
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Bradycardia Treatment Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Devices
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Bradycardia Treatment Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Devices
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Bradycardia Treatment Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Abbott Laboratories
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Biotronik
• 14.3. Nihon Kohden Corporation
• 14.4. Lepu Medical Technology (Beijing)Co Ltd.
• 14.5. Medico S.R.L.
• 14.6. Oscor Inc
• 14.7. Osypka Medical Inc.
• 14.8. Microport Scientific Corporation
• 14.9. Boston Scientific Corporation
• 14.10.Medtronic Plc.

15. Strategic Recommendations

16. About Us & Disclaimer